Healthcare -
Biotechnology - NASDAQ - US
$ 3.43
1.35 %
$ 9.3 M
Market Cap
-2.49
P/E
CYCN - REVENUE
Revenue CYCN - Cyclerion Therapeutics, Inc.
2 M
LAST VALUE
159.50%
2 YEAR CAGR
-15.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR